Advertisement

Psychological and Psychiatric Consequences of Cannabis

  • Bruce Phariss
  • Robert B. Millman
  • Ann Bordwine Beeder
Chapter

Abstract

Cannabis, particularly as smoked as marijuana cigarettes (“joint,” “reefer,” “herb”), is the most frequently abused illicit substance in the United States. Not surprisingly, psychologists and other mental professionals are asked to evaluate large numbers of often youthful people with psychiatric and behavioral problems who also use cannabis. In some individuals, the cannabis use clearly leads to the psychological and psychiatric consequences observed by the clinician. In others, the psychopathology noted antedates the cannabis use or dependence and is a determinate of drug use. Both the drug use and the psychopathology may also occur concurrently and be relatively independent of each other. Further complicating the picture, other illicit drugs and alcohol are often used in association with cannabis. The intermittent or occasional use of cannabis may not be associated with any psychological or psychiatric consequences.

Keywords

Borderline Personality Disorder Heavy User Marijuana User Chronic User Neuroleptic Medication 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alcoholism and Drug Addiction Research Foundation/World Health Organization. (1981). Report of an ARF/WHO Scientific Meeting on Adverse Health and Behavioral Consequences of Cannabis Use. Toronto, Ontario, Canada: Author.Google Scholar
  2. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders ( 4th ed. ). Washington, DC: Author.Google Scholar
  3. Ames, E. (1958). A clinical and metabolic study of acute intoxication with Cannabis sativa and its role in the model psychoses. Journal of Mental Science, 104, 972–999.PubMedGoogle Scholar
  4. Andreasson, S., Allenbeck, P., & Rydberg, U. (1989). Schizophrenia in users and non-users of cannabis: A longitudinal study in Stockholm county. Acta Psychiatrica Scandinavica, 79, 505–510.PubMedCrossRefGoogle Scholar
  5. Beaubrun, M., & Knight, E (1973). Psychiatric assessment of 30 chronic users of cannabis and 30 matched controls. American Journal of Psychiatry, 130, 309–311.PubMedGoogle Scholar
  6. Beeder, A. B., & Millman, R. B. (1992). Treatment of patients with psychopathology and substance abuse. In J. H. Lowinson, P. Ruiz, R. B. Millman, & John Langrod (Eds.), Substance abuse: A comprehensive textbook ( 2nd ed., pp. 675–690 ). Baltimore: Williams & Wilkins.Google Scholar
  7. Bernhardson, G., & Gunne, L. M. (1972). Forty-six cases of psychosis in cannabis abusers. International Journal of the Addictions, 7, 9–16.PubMedGoogle Scholar
  8. Brady, J. V., Foltin, R. W, Fischman. M. W., & Capriotti, R. M. (1986). Behavioral interactions and the effects of marijuana. Alcohol, Drugs, and Driving, 2, 93–103.Google Scholar
  9. Breier, A., Buchanan, R. W., Kirkpatrick, B., Davis, O. R., Irish, D., Summerfelt, A., & Carpenter, W. T. (1994). Effects of Clozapine on positive and negative symptoms in outpatients with schizophrenia. American Journal of Psychiatry, 151, 20–26.PubMedGoogle Scholar
  10. Brill, H., & Nahas, G. G. (1984). Cannabis intoxication and mental illness. In G. G. Nahas (Ed.), Marijuana in science and medicine (pp. 263–305 ). New York: Raven.Google Scholar
  11. Carter, W. E. (1980). Cannabis in Costa Rica: A study of chronic marijuana use. Philadelphia: Institute for the Study of Human Issues.Google Scholar
  12. Chaudry, H. R., Moss, H. B., Bashir, A., & Suliman, T. (1991). Cannabis psychosis following bhang ingestion. British Journal of Addiction, 86, 1075–1081.PubMedCrossRefGoogle Scholar
  13. Chopra, G., & Smith, J. (1974). Psychotic reactions following cannabis use in East Indians. Archives of General Psychiatry, 30, 24–27.PubMedCrossRefGoogle Scholar
  14. Clayton, R. R., & Voss, H. L. (1981). Young men and drugs in Manhattan: A casual analysis (NIDA Research Monograph No. 39 ). Washington, DC: U.S. Government Printing Office.Google Scholar
  15. Edwards, G. (1983). Psychopathology of a drug experience. British Journal of Psychiatry, 143, 509–512.PubMedCrossRefGoogle Scholar
  16. Ellis, G. M., Mann, M. A., Judson, B. A., Schramm, N. T., & Taschian, A. (1985). Excretion patterns of cannabinoid metabolites after last use in a group of chronic users. Clinical Pharmacology Therapeutics, 38, 572–578.CrossRefGoogle Scholar
  17. Estroff, T. W. & Gold, M. S. (1986). Psychiatric presentations of marijuana abuse. Psychiatric Annals, 16, 221–224.Google Scholar
  18. Ghodse, H. (1986). Cannabis psychosis. British Journal of Addiction, 81, 473–478.PubMedCrossRefGoogle Scholar
  19. Grinspoon, L., & Bakalar, J. B. (1986). Psychedelics and arylcyclohexylamines. In A. J. Frances & R. E. Hales (Eds.), Psychiatry update: American Psychiatric Association annual review (Vol. 5, pp. 212–225 ). Washington, DC: American Psychiatric Press.Google Scholar
  20. Hall, W., Solowij, N., & Lemon, J. (1994). The health and psychological effects of cannabis (National Drug Strategy Monograph No. 25 ). Canberra, Australia: Australian Government Publishing Service.Google Scholar
  21. Hammer, T. (1990). Per Vaglum: Initiation, continuation, or discontinuation of cannabis use in the general population. British Journal ofAddiction, 85, 899–909.CrossRefGoogle Scholar
  22. Harding, T., & Knight, F. (1973). Marijuana-modified mania. Archives of General Psychiatry, 29, 635–637.PubMedCrossRefGoogle Scholar
  23. Hunt, C. A., & Jones, R. T. (1980). Tolerance and disposition of tetrahydrocannabinol in man. Journal of Pharmacology and Experimental Therapeutics, 215, 35–44.PubMedGoogle Scholar
  24. Jessor, R. (1975). Predicting time of marijuana use: A developmental study of high school youths. In D. J. Lettieri (Ed.), Predicting adolescent drug abuse: A review of issues, methods, and correlates: Research issues, 11. Rockville, MD: National Institute on Drug Abuse.Google Scholar
  25. Jessor, R.. & Jessor, S. L. (1977). Problem behavior and psychosocial development: A longitudinal stuck of youth. New York: Academic Press.Google Scholar
  26. Jessor, R., Chase, J. A., & Donovan, J. E. (1980). Psychosocial correlates of marijuana use and problem drinking in a national sample of adolescents. American Journal of Public Health, 70, 604–613.PubMedCrossRefGoogle Scholar
  27. Jessor, R., Donovan, J., & Costa, E (1986). Psychoactive correlates of marijuana in adolescent and young adulthood: The past as prologue, in marijuana, cocaine, and traffic society. In H. Moskowitz (Ed.), Alcohol, drugs and driving (Vol. 2, pp. 31–49 ). Santa Monica, CA.Google Scholar
  28. Johansson, E., Agurell, S., Hollister, L. E., & Halldin, M. M. (1988). Prolonged apparent half-life of delta-l-tetrahydrocannabinol in plasma of chronic marijuana users. Journal of Pharmacy and Pharmacology, 40, 374–375.PubMedCrossRefGoogle Scholar
  29. Johnson, B. A. (1990). Psychopharmacological effects of cannabis. British Journal of Hospital Medicine, 43, 114–122.PubMedGoogle Scholar
  30. Jones, R. T., & Benowitz, N. (1976). The 30-day trip-Clinical studies of cannabis tolerance and dependence. In M. C. Braude & S. Szara (Eds.), The pharmacology of marijuana (pp. 627–642 ). New York: Raven.Google Scholar
  31. Jones, R. T., Benowitz, N., & Bachman, J. (1976). Clinical studies of cannabis tolerance and dependence. Annals of the New York Academy of Sciences, 282, 221–239.PubMedCrossRefGoogle Scholar
  32. Jones, R. T., Benowitz, N. L., & Fleming, R. I. (1981). Clinical relevance of cannabis tolerance and dependence. Journal of Clinical Pharmacology, 21 (Suppl.), 143S - I52S.PubMedCrossRefGoogle Scholar
  33. Kandel, D. B. (Ed). (1978). Longitudinal research on drug use: Empirical. findings and methodological issues. Washington, DC: Hemisphere.Google Scholar
  34. Kandel, D. B., & Davies, M. (1992). Progression to regular marijuana involvement: Phenomenology and risk factors for near-daily use. In M. Glantz & R. Pickens (Eds.), Vulnerability to drug abuse (pp. 211–254 ). Washington, DC: American Psychological Association.CrossRefGoogle Scholar
  35. Kandel, D. B., Kessler, R., & Margulies, R. (1978). Antecedents of adolescent initiation into stages of drug use: A developmental analysis. In D. B. Kandel (Ed.), Longitudinal research on drug use: Empirical findings and methodological issues (pp. 73–99 ). Washington, DC: Hemisphere.Google Scholar
  36. Keup, W. (1970). Psychotic symptoms due to cannabis abuse. Diseases of the Nervous System, 31, 119–126.PubMedGoogle Scholar
  37. Khantzian, E. J., & McKenna, G. J. (1979). Acute toxic and withdrawal reactions associated with drug use and abuse. Annals of Internal Medicine, 90, 361–373.PubMedGoogle Scholar
  38. Kiplinger, G. G., & Manno, J. E. (1971). Dose response relationships to cannabis in human subjects. Pharmacological Review, 23, 339–347.Google Scholar
  39. Knight, F. (1976). Role of cannabis in psychiatric disturbance. Annals of the New York Academy of Sciences, 282, 64–71.PubMedCrossRefGoogle Scholar
  40. Knudsen, P., & Vilmar, T. (1984). Cannabis and neuroleptic agents in schizophrenia. Acta Psychiatrica Scandinavica, 69, 162–174.PubMedCrossRefGoogle Scholar
  41. Kouri, E., Pope, H. G., Yurgelun-Todd, D., & Gruber, S. (1995). Attributes of heavy vs. occasional marijuana smokers in a college population. Biological Psychiatry. 38, 475–481.PubMedCrossRefGoogle Scholar
  42. Lex, B. W., Griffin, M. L., Mello, N. K., & Mendelson, J. (1989). Alcohol, marijuana and mood states in young women. International Journal of the Addictions, 24, 405–424.PubMedGoogle Scholar
  43. Marder, S. R., & Meibach, R. C. (1994). Risperidone in the treatment of schizophrenia. American Journal of Psychiatry, 151, 825–835.PubMedGoogle Scholar
  44. Marlotte, D. B. (1972). Marijuana and mutism. American Journal of Psychiatry, 129, 475–477.Google Scholar
  45. Mathers, D. C., Ghodse, A. H., Cann, A. W., & Scott, S. A. (1991). Cannabis use in a large sample of acute psychiatric admissions. British Journal of Addiction, 86, 779–784.PubMedCrossRefGoogle Scholar
  46. McLellan, A. T., Woody, G. E., & O’Brien, C. P. (1979). Development of psychiatric illness in drug abusers: Possible role of drug preference. New England Journal of Medicine, 301, 1310–1314.CrossRefGoogle Scholar
  47. Mendelson, J. H., Mello, N. K., Lex, B. W., & Bavli, S. (1984). Marijuana withdrawal syndrome in a woman. American Journal of Psychiatry, 141, 1289–1290.PubMedGoogle Scholar
  48. Mendhiratta, S. S., Varma, V. K., Dang, R., Malhotra, A. K., Das, K., & Nehra, R. (1988). Cannabis and cognitive functions: A re-evaluation study. British Journal ofAddictions, 20, 57–65.Google Scholar
  49. Millman, R. B., & Beeder. A. B. (1994). Treatment of patients for specific drugs of abuse: Cannabis. In M. Galanter & H. D. Kleber (Eds.), The American Psychiatric Press textbook of substance abuse treatment (pp. 91–109 ). Washington, DC: American Psychiatric Press.Google Scholar
  50. Millman, R. B., & Sbriglio, R. (1986). Patterns of use and psychopathology in chronic marijuana users. Psychiatric Clinics of North America, 9, 533–545.PubMedGoogle Scholar
  51. Musty, R. E., & Kaback, L. (1995). Relationships between motivation and depression in chronic marijuana users. Life Sciences, 56, 2151–2158.PubMedCrossRefGoogle Scholar
  52. National Institute on Drug Abuse. (1995). The monitoring the future study, Institute for Social Research. Ann Arbor: University of Michigan Press.Google Scholar
  53. Negrete, J. C. (1988). What’s happened to the cannabis de- bate? British Journal of Addiction, 83, 359–372.PubMedCrossRefGoogle Scholar
  54. Nicholi, A. A. (1983). The non-therapeutic use of psychoactive drugs: A modern epidemic. New England Journal of Medicine, 308, 925–933.PubMedCrossRefGoogle Scholar
  55. O’Connell, D. E (1990). Managing the dually diagnosed patient. In D. F. O’Connell (Ed.), Current issues and clinical approaches. New York: Haworth.Google Scholar
  56. O’Donnell, J. A., & Clayton, R. R. (1979). The stepping stone hypothesis: A reappraisal. In G. M. Beschner & A. S. Friedman (Eds.), Youth drug abuse: Problems, issues and treatment. Lexington, MA: Lexington Books.Google Scholar
  57. O’Donnell, J. A., Voss, H. L., Clayton, R. R., Slatin, G. T., & Room, R. G. (1976). Young men and drugs: A nationwide survey (NIDA Research Monograph No. 5; DHEW Publication No. ADM-76–311). Washington, DC: U.S. Government Printing Office.Google Scholar
  58. O’Malley, P. M., Johnston, L. D., & Bachman, J. G. (1985). Cocaine use among American adolescents and young adults. In N. J. Kozel & E. H. Adams (Eds.), Cocaine use in America: Epidemiologic and clinical perspectives (NIDA Research Monograph No. 61, pp. 50–75 ). Washington, DC: National Institute on Drug Abuse.Google Scholar
  59. Palsson, A., Thulin, S. O., & Tunving, K. (1982). Cannabis psychosis in South Sweden. Acta Psychiatrica Scandinavica, 66, 311–321.PubMedCrossRefGoogle Scholar
  60. Pope, H. G., & Yurgelun-Todd, D. (1996). The residual cognitive effects of heavy marijuana use in college students. Journal of the American Medical Association, 7, 521–527.CrossRefGoogle Scholar
  61. Pope, H. G., Gruber, A. J., & Yurgelun-Todd, D. (1995). The residual neuropsychological effects of cannabis: The current status of research. Drug and Alcohol Dependence, 38, 25–34.PubMedCrossRefGoogle Scholar
  62. Rohr, J. M., Showlund, S. W, & Martin, T. E. (1989). Withdrawal sequelae to cannabis use. International Journal of the Addictions, 14, 627–631.Google Scholar
  63. Rubin V, & Comitas, L. (1975). Psychological assessment. In V. Rubin & L. Comitas (Eds.), Ganja in Jamaica: A medical-anthropological study of chronic marijuana use (pp. 111–119 ). The Hague, Netherlands: Mouton.Google Scholar
  64. Rubin, V., & Comitas, L. (1976). Ganja in Jamaica: The effects of marijuana. New York: Anchor/Doubleday.Google Scholar
  65. Schwartz, R. H., Gruenwald, E J., Klitzner, M., & Fedio, P. (1989). Short-term memory impairment in cannabis-dependent adolescents. American Journal of Diseases of Children, 143, 1214–1219.PubMedGoogle Scholar
  66. Seth, R., & Sinha, S. (1991). Chemistry and pharmacology of cannabis. Progress in Drug Research, 36, 71–115.PubMedGoogle Scholar
  67. Smith, D. E. (1968). Acute and chronic toxicity of mari- juana. Journal of Psychedelic Drugs, 2, 37–47.CrossRefGoogle Scholar
  68. Solomons, K., & Neppe, V. M. (1989). Cannabis-Its clinical effects. South African Medical Journal, 76, 102–104.PubMedGoogle Scholar
  69. Stefanis, C., Boulougouris. I., & Liakos, A. (1976). Clinical and psychophysiological effects of cannabis in long-term users. In M. C. Brause & S. Szara (Eds.), Pharmacology of marijuana. New York: Raven.Google Scholar
  70. Substance Abuse and Mental Health Services Administration. (1995). Preliminary estimates fions the 1994 National Household Survey on Drug Abuse, Advance Report No. 10. Washington, DC: U.S. Government Printing Office.Google Scholar
  71. Thomicroft, G. (1990). Cannabis and psychosis-Is there epidemiological evidence for an association? British Journal of Psychiatry, 157, 25–33.CrossRefGoogle Scholar
  72. Tien, A. Y., & Anthony, J. C. (1990). Epidemiological analysis of alcohol and drug use as risk factors for psychotic experiences. Journal of Nervous and Mental Disease, 178, 473–480.PubMedGoogle Scholar
  73. Tunving, K. (1985). Psychiatric effects of cannabis use. Acta Psychiatrica Scandinavica, 72, 209–217.PubMedCrossRefGoogle Scholar
  74. Wall, M. E., & Perez-Reyes, M. (1981). The metabolism of delta-9-tetrahydrocannabinol and related cannabinoids in man. Journal of Clinical Pharmacology, 21, 1785–1795.Google Scholar
  75. Zablocki, B., Aidala, A., Hansell, S., & White, H. R. (1991). Marijuana use, introspectiveness, and mental health. Journal of Health and Social Behavior, 32, 65–79.PubMedCrossRefGoogle Scholar
  76. Zinberg, N. (1984). Drug, set and setting. New Haven, CT: Yale University Press.Google Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • Bruce Phariss
    • 1
  • Robert B. Millman
    • 1
  • Ann Bordwine Beeder
    • 1
  1. 1.Cornell University Medical CollegeNew YorkUSA

Personalised recommendations